Two vaccine candidates set to join DR Congo Ebola trial
WHO plans to add ChAdOx1 and mRNA-1469 to the DR Congo Bundibugyo Ebola trial following national approvals.
Original source ↗Additional Ebola vaccine candidates are due to join trials after national approvals. Water disruption undermines infection control and care; flood recovery in Nepal and medical-equipment investment in the Dominican Republic also affect local recovery.
WHO plans to add ChAdOx1 and mRNA-1469 to the DR Congo Bundibugyo Ebola trial following national approvals.
Original source ↗UNICEF reported that attacks on water and sanitation rose from fewer than 45 in 2021 to over 135 in 2025. Its study covers January 2021–June 2026.
Original source ↗The UN reported on 5 November that August floods damaged homes, power grids and 115 bridges. Estimated recovery costs are $4.7 billion.
Original source ↗The SNS announced operation of a laparoscopic unit at Alejandro Cabral hospital on 5 November, within more than RD15 million of regional equipment and facility investment.
Original source ↗